Singulex, Inc. Announces Expansion Of National Sales Force For Clinical Lab Business
ALAMEDA, Calif.--(BUSINESS WIRE)--Singulex, Inc., the developer and leading provider of Single Molecule Counting (SMC) technology for clinical diagnostics and scientific discovery, today outlined a refinement of the Company’s commercial strategy which will expand its Clinical Lab Testing Services direct sales force throughout the United States. In conjunction with this expansion, Singulex also announced the termination of its sales agreement with BlueWave Healthcare Consultants, Inc., an independent contract sales organization.
“As more physicians recognize the clinical value of our SMC™ technology to measure important changes in biomarker levels, demand continues to grow for our SMC™ high value tests. The nationwide expansion of our direct sales force will enable us to provide the best possible support to our growing customer base,” said Guido Baechler, President and Chief Executive Officer of Singulex.
Help employers find you! Check out all the jobs and post your resume.
“As more physicians recognize the clinical value of our SMC™ technology to measure important changes in biomarker levels, demand continues to grow for our SMC™ high value tests. The nationwide expansion of our direct sales force will enable us to provide the best possible support to our growing customer base,” said Guido Baechler, President and Chief Executive Officer of Singulex.
Help employers find you! Check out all the jobs and post your resume.